What is SRPT's dilution risk score?

SRPT has a latest available DilutionScore record of 52/100, categorized as high dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for SRPT, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for SRPT?

DilutionWatch tracks 25 SEC filing types for SRPT including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect SRPT shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For SRPT, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for SRPT tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for SRPT. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

SRPT Dilution Risk Score: 52/100 (HIGH)

Score Breakdown

📋 Offering Ability

40

💰 Cash Runway

65

📊 Float Risk

25

⚠️ Warrant Exposure

40

🔄 Convertible Debt

85

Dilution Forecast

⛈️

Warning

High probability of dilution event

model est. 34%

🔁 Convertible Conversion model 60%

• Major convertible overhang: 30% potential dilution

• Convertible risk score very high (85/100)

💰 Capital Raise model 15%

• Under 12 months cash (8mo)

🔔 Track SRPT — Get forecast alerts →

Market Data

Market Cap$1.89B

Shares Outstanding105.63M

Float94.80M

Cash$788.49M

Debt$1.45M

Short InterestN/A

Institutional Holdings

QoQ: ↑ 21.9% shares (2026Q1 vs prior)

344 institutional holders · 127.57M shares

#1 BlackRock, Inc. 14.76M shares

#2 VANGUARD CAPITAL MANAGEMENT LLC 9.16M shares

#3 VANGUARD PORTFOLIO MANAGEMENT LLC 6.64M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest27.57M

Days to Cover8.8

% of Float29.1%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2025-12-31

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual SRPT Dilution Snapshot

Sarepta Therapeutics, Inc. (SRPT) has a DilutionScore of 52/100, rated High dilution risk. Score date: August 28, 2026.

Recent SEC activity tracked for SRPT: xbrl on 2025-12-31.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.